APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gastric Cancer Diagnostic Procedure

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Gastric Cancer Diagnostic Procedure Industry Growth and Trends Forecast to 2032

5 March 2026112 pages

Choose your research edition.

Industry ResearchGastric Cancer Diagnostic Procedure Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Gastric Cancer Diagnostic Procedure Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Gastric Cancer Diagnostic Procedure Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gastric Cancer Diagnostic Procedure Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Gastric Cancer Diagnostic Procedure Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

According to APO Research, the global Gastric Cancer Diagnostic Procedure market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Gastric Cancer Diagnostic Procedure is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Gastric Cancer Diagnostic Procedure is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gastric Cancer Diagnostic Procedure is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Gastric Cancer Diagnostic Procedure market include Pfizer Inc., Johnson & Johnson Co, F.Hoffmann La Roche, Merck & Co. Ilnc, Bayer AG, Novartis AG, Bristol-Myers Squibb Company, ThermoFisher Scientific Inc and AstraZeneca plc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Gastric Cancer Diagnostic Procedure market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Gastric Cancer Diagnostic Procedure market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Gastric Cancer Diagnostic Procedure market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Gastric Cancer Diagnostic Procedure.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Gastric Cancer Diagnostic Procedure market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Gastric Cancer Diagnostic Procedure Market by Company

Pfizer Inc.

Johnson & Johnson Co

F.Hoffmann La Roche

Merck & Co. Ilnc

Bayer AG

Novartis AG

Bristol-Myers Squibb Company

ThermoFisher Scientific Inc

AstraZeneca plc

Abbott Laboratories Inc

Sanof SA

Eli Lilly and Company

OtsukaPharmaceutical Co Ltd

AdventHealth, Atrium Health

Astellas Pharma Inc

Bausch Health Companies Inc

Gastric Cancer Diagnostic Procedure Segment by Type

Instrument

Test Strips and Consumables

Service

Gastric Cancer Diagnostic Procedure Segment by Application

Early Gastric Cancer

Advanced Gastric Cancer

Gastric Cancer Diagnostic Procedure Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gastric Cancer Diagnostic Procedure market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gastric Cancer Diagnostic Procedure and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gastric Cancer Diagnostic Procedure.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Gastric Cancer Diagnostic Procedure companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Gastric Cancer Diagnostic Procedure Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Gastric Cancer Diagnostic Procedure Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Gastric Cancer Diagnostic Procedure Market Share by Region (2021-2026) Table 4. Global Gastric Cancer Diagnostic Procedure Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Gastric Cancer Diagnostic Procedure Market Share by Region (2027-2032) Table 6. Global Gastric Cancer Diagnostic Procedure Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Gastric Cancer Diagnostic Procedure Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Gastric Cancer Diagnostic Procedure Market Size Share by Type (2021-2026) Table 9. Global Gastric Cancer Diagnostic Procedure Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Gastric Cancer Diagnostic Procedure Market Size Share Forecasted by Type (2027-2032) Table 11. North America Gastric Cancer Diagnostic Procedure Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Gastric Cancer Diagnostic Procedure Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Gastric Cancer Diagnostic Procedure Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Gastric Cancer Diagnostic Procedure Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Gastric Cancer Diagnostic Procedure Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Gastric Cancer Diagnostic Procedure Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Gastric Cancer Diagnostic Procedure Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Gastric Cancer Diagnostic Procedure Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Gastric Cancer Diagnostic Procedure Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Gastric Cancer Diagnostic Procedure Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Gastric Cancer Diagnostic Procedure Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Gastric Cancer Diagnostic Procedure Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Gastric Cancer Diagnostic Procedure Market Size Share by Application (2021-2026) Table 24. Global Gastric Cancer Diagnostic Procedure Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Gastric Cancer Diagnostic Procedure Market Size Share Forecasted by Application (2027-2032) Table 26. North America Gastric Cancer Diagnostic Procedure Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Gastric Cancer Diagnostic Procedure Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Gastric Cancer Diagnostic Procedure Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Gastric Cancer Diagnostic Procedure Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Gastric Cancer Diagnostic Procedure Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Gastric Cancer Diagnostic Procedure Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Gastric Cancer Diagnostic Procedure Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Gastric Cancer Diagnostic Procedure Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Gastric Cancer Diagnostic Procedure Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Gastric Cancer Diagnostic Procedure Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Gastric Cancer Diagnostic Procedure Industry Trends Table 37. Gastric Cancer Diagnostic Procedure Industry Drivers Table 38. Gastric Cancer Diagnostic Procedure Industry Opportunities and Challenges Table 39. Gastric Cancer Diagnostic Procedure Industry Restraints Table 40. Global Gastric Cancer Diagnostic Procedure Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Gastric Cancer Diagnostic Procedure Revenue Market Share by Company (2021-2026) Table 42. Global Gastric Cancer Diagnostic Procedure Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Gastric Cancer Diagnostic Procedure Key Company Headquarters & Area Served Table 44. Global Gastric Cancer Diagnostic Procedure Company, Product Type & Application Table 45. Global Gastric Cancer Diagnostic Procedure Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Gastric Cancer Diagnostic Procedure by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Pfizer Inc. Company Information Table 49. Pfizer Inc. Business Overview Table 50. Pfizer Inc. Gastric Cancer Diagnostic Procedure Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Pfizer Inc. Gastric Cancer Diagnostic Procedure Product Portfolio Table 52. Pfizer Inc. Recent Development Table 53. Johnson & Johnson Co Company Information Table 54. Johnson & Johnson Co Business Overview Table 55. Johnson & Johnson Co Gastric Cancer Diagnostic Procedure Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Johnson & Johnson Co Gastric Cancer Diagnostic Procedure Product Portfolio Table 57. Johnson & Johnson Co Recent Development Table 58. F.Hoffmann La Roche Company Information Table 59. F.Hoffmann La Roche Business Overview Table 60. F.Hoffmann La Roche Gastric Cancer Diagnostic Procedure Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. F.Hoffmann La Roche Gastric Cancer Diagnostic Procedure Product Portfolio Table 62. F.Hoffmann La Roche Recent Development Table 63. Merck & Co. Ilnc Company Information Table 64. Merck & Co. Ilnc Business Overview Table 65. Merck & Co. Ilnc Gastric Cancer Diagnostic Procedure Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Merck & Co. Ilnc Gastric Cancer Diagnostic Procedure Product Portfolio Table 67. Merck & Co. Ilnc Recent Development Table 68. Bayer AG Company Information Table 69. Bayer AG Business Overview Table 70. Bayer AG Gastric Cancer Diagnostic Procedure Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Bayer AG Gastric Cancer Diagnostic Procedure Product Portfolio Table 72. Bayer AG Recent Development Table 73. Novartis AG Company Information Table 74. Novartis AG Business Overview Table 75. Novartis AG Gastric Cancer Diagnostic Procedure Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Novartis AG Gastric Cancer Diagnostic Procedure Product Portfolio Table 77. Novartis AG Recent Development Table 78. Bristol-Myers Squibb Company Company Information Table 79. Bristol-Myers Squibb Company Business Overview Table 80. Bristol-Myers Squibb Company Gastric Cancer Diagnostic Procedure Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Bristol-Myers Squibb Company Gastric Cancer Diagnostic Procedure Product Portfolio Table 82. Bristol-Myers Squibb Company Recent Development Table 83. ThermoFisher Scientific Inc Company Information Table 84. ThermoFisher Scientific Inc Business Overview Table 85. ThermoFisher Scientific Inc Gastric Cancer Diagnostic Procedure Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. ThermoFisher Scientific Inc Gastric Cancer Diagnostic Procedure Product Portfolio Table 87. ThermoFisher Scientific Inc Recent Development Table 88. AstraZeneca plc Company Information Table 89. AstraZeneca plc Business Overview Table 90. AstraZeneca plc Gastric Cancer Diagnostic Procedure Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. AstraZeneca plc Gastric Cancer Diagnostic Procedure Product Portfolio Table 92. AstraZeneca plc Recent Development Table 93. Abbott Laboratories Inc Company Information Table 94. Abbott Laboratories Inc Business Overview Table 95. Abbott Laboratories Inc Gastric Cancer Diagnostic Procedure Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Abbott Laboratories Inc Gastric Cancer Diagnostic Procedure Product Portfolio Table 97. Abbott Laboratories Inc Recent Development Table 98. Sanof SA Company Information Table 99. Sanof SA Business Overview Table 100. Sanof SA Gastric Cancer Diagnostic Procedure Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Sanof SA Gastric Cancer Diagnostic Procedure Product Portfolio Table 102. Sanof SA Recent Development Table 103. Eli Lilly and Company Company Information Table 104. Eli Lilly and Company Business Overview Table 105. Eli Lilly and Company Gastric Cancer Diagnostic Procedure Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Eli Lilly and Company Gastric Cancer Diagnostic Procedure Product Portfolio Table 107. Eli Lilly and Company Recent Development Table 108. OtsukaPharmaceutical Co Ltd Company Information Table 109. OtsukaPharmaceutical Co Ltd Business Overview Table 110. OtsukaPharmaceutical Co Ltd Gastric Cancer Diagnostic Procedure Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. OtsukaPharmaceutical Co Ltd Gastric Cancer Diagnostic Procedure Product Portfolio Table 112. OtsukaPharmaceutical Co Ltd Recent Development Table 113. AdventHealth, Atrium Health Company Information Table 114. AdventHealth, Atrium Health Business Overview Table 115. AdventHealth, Atrium Health Gastric Cancer Diagnostic Procedure Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. AdventHealth, Atrium Health Gastric Cancer Diagnostic Procedure Product Portfolio Table 117. AdventHealth, Atrium Health Recent Development Table 118. Astellas Pharma Inc Company Information Table 119. Astellas Pharma Inc Business Overview Table 120. Astellas Pharma Inc Gastric Cancer Diagnostic Procedure Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Astellas Pharma Inc Gastric Cancer Diagnostic Procedure Product Portfolio Table 122. Astellas Pharma Inc Recent Development Table 123. Bausch Health Companies Inc Company Information Table 124. Bausch Health Companies Inc Business Overview Table 125. Bausch Health Companies Inc Gastric Cancer Diagnostic Procedure Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Bausch Health Companies Inc Gastric Cancer Diagnostic Procedure Product Portfolio Table 127. Bausch Health Companies Inc Recent Development Table 128. North America Gastric Cancer Diagnostic Procedure Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Gastric Cancer Diagnostic Procedure Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Gastric Cancer Diagnostic Procedure Market Share by Country (2021-2026) Table 131. North America Gastric Cancer Diagnostic Procedure Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Gastric Cancer Diagnostic Procedure Market Share Forecast by Country (2027-2032) Table 133. Europe Gastric Cancer Diagnostic Procedure Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Gastric Cancer Diagnostic Procedure Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Gastric Cancer Diagnostic Procedure Market Share by Country (2021-2026) Table 136. Europe Gastric Cancer Diagnostic Procedure Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Gastric Cancer Diagnostic Procedure Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Gastric Cancer Diagnostic Procedure Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Gastric Cancer Diagnostic Procedure Market Size by Country (2021-2026) & (US$ Million) Table 140. Asia-Pacific Gastric Cancer Diagnostic Procedure Market Share by Country (2021-2026) Table 141. Asia-Pacific Gastric Cancer Diagnostic Procedure Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Asia-Pacific Gastric Cancer Diagnostic Procedure Market Share Forecast by Country (2027-2032) Table 143. Latin America Gastric Cancer Diagnostic Procedure Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Latin America Gastric Cancer Diagnostic Procedure Market Size by Country (2021-2026) & (US$ Million) Table 145. Latin America Gastric Cancer Diagnostic Procedure Market Share by Country (2021-2026) Table 146. Latin America Gastric Cancer Diagnostic Procedure Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Latin America Gastric Cancer Diagnostic Procedure Market Share Forecast by Country (2027-2032) Table 148. Middle East & Africa Gastric Cancer Diagnostic Procedure Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East & Africa Gastric Cancer Diagnostic Procedure Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East & Africa Gastric Cancer Diagnostic Procedure Market Share by Country (2021-2026) Table 151. Middle East & Africa Gastric Cancer Diagnostic Procedure Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East & Africa Gastric Cancer Diagnostic Procedure Market Share Forecast by Country (2027-2032) Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Gastric Cancer Diagnostic Procedure Product Image Figure 3. Global Gastric Cancer Diagnostic Procedure Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Gastric Cancer Diagnostic Procedure Market Size (2021-2032) & (US$ Million) Figure 5. Global Gastric Cancer Diagnostic Procedure Market Share by Region: 2025 VS 2032 Figure 6. Global Gastric Cancer Diagnostic Procedure Market Share by Region (2021-2032) Figure 7. North America Gastric Cancer Diagnostic Procedure Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Gastric Cancer Diagnostic Procedure Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Gastric Cancer Diagnostic Procedure Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Gastric Cancer Diagnostic Procedure Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Gastric Cancer Diagnostic Procedure Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Instrument Image Figure 13. Global Instrument Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Test Strips and Consumables Image Figure 15. Global Test Strips and Consumables Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Service Image Figure 17. Global Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Gastric Cancer Diagnostic Procedure Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Gastric Cancer Diagnostic Procedure Market Share by Type 2025 VS 2032 Figure 20. North America Gastric Cancer Diagnostic Procedure Market Size Share by Type (2021-2032) Figure 21. Europe Gastric Cancer Diagnostic Procedure Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Gastric Cancer Diagnostic Procedure Market Size Share by Type (2021-2032) Figure 23. Latin America Gastric Cancer Diagnostic Procedure Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Gastric Cancer Diagnostic Procedure Market Size Share by Type (2021-2032) Figure 25. Early Gastric Cancer Image Figure 26. Global Early Gastric Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Advanced Gastric Cancer Image Figure 28. Global Advanced Gastric Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Gastric Cancer Diagnostic Procedure Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Gastric Cancer Diagnostic Procedure Market Share by Application 2025 VS 2032 Figure 31. North America Gastric Cancer Diagnostic Procedure Market Size Share by Application (2021-2032) Figure 32. Europe Gastric Cancer Diagnostic Procedure Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Gastric Cancer Diagnostic Procedure Market Size Share by Application (2021-2032) Figure 34. Latin America Gastric Cancer Diagnostic Procedure Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Gastric Cancer Diagnostic Procedure Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Gastric Cancer Diagnostic Procedure Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Gastric Cancer Diagnostic Procedure Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Gastric Cancer Diagnostic Procedure Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Gastric Cancer Diagnostic Procedure Market Share by Country (2021-2032) Figure 41. Europe Gastric Cancer Diagnostic Procedure Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Gastric Cancer Diagnostic Procedure Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Gastric Cancer Diagnostic Procedure Market Share by Country (2021-2032) Figure 44. Asia-Pacific Gastric Cancer Diagnostic Procedure Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Gastric Cancer Diagnostic Procedure Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Gastric Cancer Diagnostic Procedure Market Share by Country (2021-2032) Figure 47. Latin America Gastric Cancer Diagnostic Procedure Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Gastric Cancer Diagnostic Procedure Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Gastric Cancer Diagnostic Procedure Market Share by Country (2021-2032) Figure 50. Middle East & Africa Gastric Cancer Diagnostic Procedure Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Gastric Cancer Diagnostic Procedure Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Gastric Cancer Diagnostic Procedure Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Instrument
  • Test Strips and Consumables
  • Service
Applications
  • Early Gastric Cancer
  • Advanced Gastric Cancer
Companies covered
  • Pfizer Inc.
  • Johnson & Johnson Co
  • F.Hoffmann La Roche
  • Merck & Co. Ilnc
  • Bayer AG
  • Novartis AG
  • Bristol-Myers Squibb Company
  • ThermoFisher Scientific Inc
  • AstraZeneca plc
  • Abbott Laboratories Inc
  • Sanof SA
  • Eli Lilly and Company
  • OtsukaPharmaceutical Co Ltd
  • AdventHealth, Atrium Health
  • Astellas Pharma Inc
  • Bausch Health Companies Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Gastric Cancer Diagnostic Procedure Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Gastric Cancer Diagnostic Procedure Market Size by Region (2021-2032)
  5. 1.4.1 Global Gastric Cancer Diagnostic Procedure Market Size by Region (2021-2026)
  6. 1.4.2 Global Gastric Cancer Diagnostic Procedure Market Size by Region (2027-2032)
  7. 1.5 Key Regions Gastric Cancer Diagnostic Procedure Market Size (2021-2032)
  8. 1.5.1 North America Gastric Cancer Diagnostic Procedure Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Gastric Cancer Diagnostic Procedure Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Gastric Cancer Diagnostic Procedure Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Gastric Cancer Diagnostic Procedure Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Gastric Cancer Diagnostic Procedure Market Size Growth Rate (2021-2032)
2 Gastric Cancer Diagnostic Procedure Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Instrument
  3. 2.1.2 Test Strips and Consumables
  4. 2.1.3 Service
  5. 2.2 Global Gastric Cancer Diagnostic Procedure Market Size by Type
  6. 2.2.1 Global Gastric Cancer Diagnostic Procedure Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Gastric Cancer Diagnostic Procedure Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Gastric Cancer Diagnostic Procedure Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Gastric Cancer Diagnostic Procedure Market Size by Regions
  10. 2.3.1 North America Gastric Cancer Diagnostic Procedure Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Gastric Cancer Diagnostic Procedure Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Gastric Cancer Diagnostic Procedure Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Gastric Cancer Diagnostic Procedure Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Gastric Cancer Diagnostic Procedure Market Size Breakdown by Type (2021-2026)
3 Gastric Cancer Diagnostic Procedure Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Early Gastric Cancer
  3. 3.1.2 Advanced Gastric Cancer
  4. 3.2 Global Gastric Cancer Diagnostic Procedure Market Size by Application
  5. 3.2.1 Global Gastric Cancer Diagnostic Procedure Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Gastric Cancer Diagnostic Procedure Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Gastric Cancer Diagnostic Procedure Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Gastric Cancer Diagnostic Procedure Market Size by Regions
  9. 3.3.1 North America Gastric Cancer Diagnostic Procedure Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Gastric Cancer Diagnostic Procedure Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Gastric Cancer Diagnostic Procedure Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Gastric Cancer Diagnostic Procedure Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Gastric Cancer Diagnostic Procedure Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Gastric Cancer Diagnostic Procedure Industry Trends
  2. 4.2 Gastric Cancer Diagnostic Procedure Industry Drivers
  3. 4.3 Gastric Cancer Diagnostic Procedure Industry Opportunities and Challenges
  4. 4.4 Gastric Cancer Diagnostic Procedure Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Gastric Cancer Diagnostic Procedure Revenue (2021-2026)
  2. 5.2 Global Gastric Cancer Diagnostic Procedure Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Gastric Cancer Diagnostic Procedure Key Company Headquarters & Area Served
  4. 5.4 Global Gastric Cancer Diagnostic Procedure Company, Product Type & Application
  5. 5.5 Global Gastric Cancer Diagnostic Procedure Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Gastric Cancer Diagnostic Procedure Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Gastric Cancer Diagnostic Procedure Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Gastric Cancer Diagnostic Procedure Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Pfizer Inc.
  2. 6.1.1 Pfizer Inc. Company Information
  3. 6.1.2 Pfizer Inc. Business Overview
  4. 6.1.3 Pfizer Inc. Gastric Cancer Diagnostic Procedure Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Pfizer Inc. Gastric Cancer Diagnostic Procedure Product Portfolio
  6. 6.1.5 Pfizer Inc. Recent Developments
  7. 6.2 Johnson & Johnson Co
  8. 6.2.1 Johnson & Johnson Co Company Information
  9. 6.2.2 Johnson & Johnson Co Business Overview
  10. 6.2.3 Johnson & Johnson Co Gastric Cancer Diagnostic Procedure Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Johnson & Johnson Co Gastric Cancer Diagnostic Procedure Product Portfolio
  12. 6.2.5 Johnson & Johnson Co Recent Developments
  13. 6.3 F.Hoffmann La Roche
  14. 6.3.1 F.Hoffmann La Roche Company Information
  15. 6.3.2 F.Hoffmann La Roche Business Overview
  16. 6.3.3 F.Hoffmann La Roche Gastric Cancer Diagnostic Procedure Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 F.Hoffmann La Roche Gastric Cancer Diagnostic Procedure Product Portfolio
  18. 6.3.5 F.Hoffmann La Roche Recent Developments
  19. 6.4 Merck & Co. Ilnc
  20. 6.4.1 Merck & Co. Ilnc Company Information
  21. 6.4.2 Merck & Co. Ilnc Business Overview
  22. 6.4.3 Merck & Co. Ilnc Gastric Cancer Diagnostic Procedure Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Merck & Co. Ilnc Gastric Cancer Diagnostic Procedure Product Portfolio
  24. 6.4.5 Merck & Co. Ilnc Recent Developments
  25. 6.5 Bayer AG
  26. 6.5.1 Bayer AG Company Information
  27. 6.5.2 Bayer AG Business Overview
  28. 6.5.3 Bayer AG Gastric Cancer Diagnostic Procedure Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Bayer AG Gastric Cancer Diagnostic Procedure Product Portfolio
  30. 6.5.5 Bayer AG Recent Developments
  31. 6.6 Novartis AG
  32. 6.6.1 Novartis AG Company Information
  33. 6.6.2 Novartis AG Business Overview
  34. 6.6.3 Novartis AG Gastric Cancer Diagnostic Procedure Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Novartis AG Gastric Cancer Diagnostic Procedure Product Portfolio
  36. 6.6.5 Novartis AG Recent Developments
  37. 6.7 Bristol-Myers Squibb Company
  38. 6.7.1 Bristol-Myers Squibb Company Company Information
  39. 6.7.2 Bristol-Myers Squibb Company Business Overview
  40. 6.7.3 Bristol-Myers Squibb Company Gastric Cancer Diagnostic Procedure Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Bristol-Myers Squibb Company Gastric Cancer Diagnostic Procedure Product Portfolio
  42. 6.7.5 Bristol-Myers Squibb Company Recent Developments
  43. 6.8 ThermoFisher Scientific Inc
  44. 6.8.1 ThermoFisher Scientific Inc Company Information
  45. 6.8.2 ThermoFisher Scientific Inc Business Overview
  46. 6.8.3 ThermoFisher Scientific Inc Gastric Cancer Diagnostic Procedure Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 ThermoFisher Scientific Inc Gastric Cancer Diagnostic Procedure Product Portfolio
  48. 6.8.5 ThermoFisher Scientific Inc Recent Developments
  49. 6.9 AstraZeneca plc
  50. 6.9.1 AstraZeneca plc Company Information
  51. 6.9.2 AstraZeneca plc Business Overview
  52. 6.9.3 AstraZeneca plc Gastric Cancer Diagnostic Procedure Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 AstraZeneca plc Gastric Cancer Diagnostic Procedure Product Portfolio
  54. 6.9.5 AstraZeneca plc Recent Developments
  55. 6.10 Abbott Laboratories Inc
  56. 6.10.1 Abbott Laboratories Inc Company Information
  57. 6.10.2 Abbott Laboratories Inc Business Overview
  58. 6.10.3 Abbott Laboratories Inc Gastric Cancer Diagnostic Procedure Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Abbott Laboratories Inc Gastric Cancer Diagnostic Procedure Product Portfolio
  60. 6.10.5 Abbott Laboratories Inc Recent Developments
  61. 6.11 Sanof SA
  62. 6.11.1 Sanof SA Company Information
  63. 6.11.2 Sanof SA Business Overview
  64. 6.11.3 Sanof SA Gastric Cancer Diagnostic Procedure Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Sanof SA Gastric Cancer Diagnostic Procedure Product Portfolio
  66. 6.11.5 Sanof SA Recent Developments
  67. 6.12 Eli Lilly and Company
  68. 6.12.1 Eli Lilly and Company Company Information
  69. 6.12.2 Eli Lilly and Company Business Overview
  70. 6.12.3 Eli Lilly and Company Gastric Cancer Diagnostic Procedure Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Eli Lilly and Company Gastric Cancer Diagnostic Procedure Product Portfolio
  72. 6.12.5 Eli Lilly and Company Recent Developments
  73. 6.13 OtsukaPharmaceutical Co Ltd
  74. 6.13.1 OtsukaPharmaceutical Co Ltd Company Information
  75. 6.13.2 OtsukaPharmaceutical Co Ltd Business Overview
  76. 6.13.3 OtsukaPharmaceutical Co Ltd Gastric Cancer Diagnostic Procedure Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 OtsukaPharmaceutical Co Ltd Gastric Cancer Diagnostic Procedure Product Portfolio
  78. 6.13.5 OtsukaPharmaceutical Co Ltd Recent Developments
  79. 6.14 AdventHealth, Atrium Health
  80. 6.14.1 AdventHealth, Atrium Health Company Information
  81. 6.14.2 AdventHealth, Atrium Health Business Overview
  82. 6.14.3 AdventHealth, Atrium Health Gastric Cancer Diagnostic Procedure Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 AdventHealth, Atrium Health Gastric Cancer Diagnostic Procedure Product Portfolio
  84. 6.14.5 AdventHealth, Atrium Health Recent Developments
  85. 6.15 Astellas Pharma Inc
  86. 6.15.1 Astellas Pharma Inc Company Information
  87. 6.15.2 Astellas Pharma Inc Business Overview
  88. 6.15.3 Astellas Pharma Inc Gastric Cancer Diagnostic Procedure Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Astellas Pharma Inc Gastric Cancer Diagnostic Procedure Product Portfolio
  90. 6.15.5 Astellas Pharma Inc Recent Developments
  91. 6.16 Bausch Health Companies Inc
  92. 6.16.1 Bausch Health Companies Inc Company Information
  93. 6.16.2 Bausch Health Companies Inc Business Overview
  94. 6.16.3 Bausch Health Companies Inc Gastric Cancer Diagnostic Procedure Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Bausch Health Companies Inc Gastric Cancer Diagnostic Procedure Product Portfolio
  96. 6.16.5 Bausch Health Companies Inc Recent Developments
7 North America
  1. 7.1 North America Gastric Cancer Diagnostic Procedure Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Gastric Cancer Diagnostic Procedure Market Size by Country (2021-2026)
  3. 7.3 North America Gastric Cancer Diagnostic Procedure Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Gastric Cancer Diagnostic Procedure Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Gastric Cancer Diagnostic Procedure Market Size by Country (2021-2026)
  3. 8.3 Europe Gastric Cancer Diagnostic Procedure Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Gastric Cancer Diagnostic Procedure Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Gastric Cancer Diagnostic Procedure Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Gastric Cancer Diagnostic Procedure Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Gastric Cancer Diagnostic Procedure Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Gastric Cancer Diagnostic Procedure Market Size by Country (2021-2026)
  3. 10.3 South America Gastric Cancer Diagnostic Procedure Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Gastric Cancer Diagnostic Procedure Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Gastric Cancer Diagnostic Procedure Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Gastric Cancer Diagnostic Procedure Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst